CSPIA
GMED icon

Cary Street Partners Investment Advisory’s Globus Medical GMED Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-85
Closed -$4.22K – 1087
2023
Q3 		$4.22K Hold
85
– – ﹤0.01% 1538
2023
Q2 		$5.06K Hold
85
– – ﹤0.01% 1411
2023
Q1 		$4.81K Hold
85
– – ﹤0.01% 1334
2022
Q4 		$6.31K Buy
+85
New +$5.79K ﹤0.01% 1271

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cary Street Partners Investment Advisory's GMED Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 85 shares — an estimated $4.22K sold.

Cary Street Partners Investment Advisory first reported a position in GMED in Q4 2022 and held it in 4 quarters. The position peaked at $6.31K in Q4 2022. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 85 Globus Medical shares in Q4 2023, an estimated $4.22K.
  • Cary Street Partners Investment Advisory first reported a position in Globus Medical in Q4 2022 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Globus Medical position peaked at $6.31K in Q4 2022.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.